Ernexa Therapeutics Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Ernexa Therapeutics Inc. (ERNA) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$272.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-11-09
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$728.00K.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $1.17M, a 67.71% increase year-over-year.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$718.00K, a 270.95% decline year-over-year.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$1.08M, a 140.16% decline year-over-year.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$2.37M, a 197.21% decline from fiscal 2016.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $2.44M.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$3.82M, a 312.98% decline from fiscal 2014.
- Ernexa Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $1.79M, a 35.76% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | -$728.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $446.00K derived: sum of 2 quarters · filed 2018-11-09 | -$272.00K 10-Q · filed 2018-11-09 | -$1.35M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $456.00K 10-Q · filed 2018-08-06 | -$623.00K derived: sum of 3 quarters · filed 2018-08-06 | -$3.04M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-03-31 | -$718.00K 10-Q · filed 2018-05-11 | -$1.80M derived: sum of 2 quarters · filed 2018-05-11 | -$4.21M derived: sum of 3 quarters · filed 2018-11-09 | -$3.51M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$3.49M derived: sum of 2 quarters · filed 2018-11-09 | -$2.79M derived: sum of 3 quarters · filed 2018-11-09 | -$2.37M 10-K · filed 2018-03-09 | |
| 2017-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$1.71M derived: sum of 2 quarters · filed 2018-11-09 | -$1.29M 10-Q · filed 2018-11-09 | $1.40M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.12M 10-Q · filed 2018-08-06 | $3.81M derived: sum of 3 quarters · filed 2018-08-06 | $3.26M derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-03-31 | $420.00K 10-Q · filed 2018-05-11 | $3.11M derived: sum of 2 quarters · filed 2018-05-11 | $2.56M derived: sum of 3 quarters · filed 2018-05-11 | $2.59M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.14M derived: sum of 2 quarters · filed 2018-03-09 | $2.17M derived: sum of 3 quarters · filed 2018-03-09 | $2.44M 10-K · filed 2018-03-09 | |
| 2016-09-30 | -$543.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$521.00K derived: sum of 2 quarters · filed 2017-11-08 | -$248.00K 10-Q · filed 2017-11-08 | -$1.68M derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $295.00K 10-Q · filed 2017-08-04 | -$1.14M derived: sum of 3 quarters · filed 2017-08-04 | -$1.78M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $273.00K 10-Q · filed 2017-05-04 | -$1.16M derived: sum of 2 quarters · filed 2017-05-04 | -$1.80M derived: sum of 3 quarters · filed 2017-05-04 | -$3.48M derived: sum of 4 quarters · filed 2017-05-04 | |
| 2015-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$2.08M derived: sum of 2 quarters · filed 2017-03-09 | -$3.75M derived: sum of 3 quarters · filed 2017-03-09 | -$3.82M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$646.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$2.32M derived: sum of 2 quarters · filed 2016-11-09 | -$2.39M 10-Q · filed 2016-11-09 | -$5.02M derived: sum of 4 quarters · filed 2016-11-09 | |
| 2015-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.75M 10-Q · filed 2016-08-04 | -$4.37M derived: sum of 3 quarters · filed 2016-08-04 | -$5.66M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | -$74.00K 10-Q · filed 2016-05-09 | -$2.70M derived: sum of 2 quarters · filed 2016-05-09 | -$3.99M derived: sum of 3 quarters · filed 2016-05-09 | $2.38M derived: sum of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$3.91M derived: sum of 2 quarters · filed 2016-03-15 | $2.46M derived: sum of 3 quarters · filed 2016-03-15 | $1.79M 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.08M derived: sum of 2 quarters · filed 2015-11-09 | $4.42M 10-Q · filed 2015-11-09 | $7.74M derived: sum of 4 quarters · filed 2015-11-09 | |
| 2014-06-30 | $6.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $5.71M 10-Q · filed 2015-08-10 | $9.03M derived: sum of 3 quarters · filed 2015-08-10 | $9.21M derived: sum of 4 quarters · filed 2015-08-10 | |
| 2014-03-31 | -$663.00K 10-Q · filed 2015-05-08 | -$664.00K 10-Q · filed 2014-05-15 | $2.66M derived: sum of 2 quarters · filed 2015-05-08 | $2.83M derived: sum of 3 quarters · filed 2015-05-08 | $2.51M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $3.50M derived: sum of 2 quarters · filed 2015-03-27 | $3.17M derived: sum of 3 quarters · filed 2015-03-27 | $2.79M 10-K · filed 2015-03-27 | |
| 2013-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$150.00K derived: sum of 2 quarters · filed 2014-11-07 | -$529.00K 10-Q · filed 2014-11-07 | -$198.00K derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-06-30 | -$325.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$704.00K 10-Q · filed 2014-08-14 | -$373.00K derived: sum of 3 quarters · filed 2014-08-14 | -$552.00K derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | -$379.00K 10-Q · filed 2014-05-15 | -$48.00K derived: sum of 2 quarters · filed 2014-05-15 | -$227.00K derived: sum of 3 quarters · filed 2014-05-15 | -$796.00K derived: sum of 4 quarters · filed 2014-05-15 | |
| 2012-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $152.00K derived: sum of 2 quarters · filed 2014-03-31 | -$417.00K derived: sum of 3 quarters · filed 2014-03-31 | $1.33M 10-K · filed 2014-03-31 | |
| 2012-09-30 | -$179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$748.00K derived: sum of 2 quarters · filed 2013-11-14 | $1.00M 10-Q · filed 2013-11-14 | -$108.00K derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | -$569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.18M 10-Q · filed 2013-08-14 | $71.00K derived: sum of 3 quarters · filed 2013-08-14 | -$519.00K derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $1.75M 10-Q · filed 2013-05-13 | $640.00K derived: sum of 2 quarters · filed 2013-05-13 | $50.00K derived: sum of 3 quarters · filed 2013-05-13 | -$894.00K derived: sum of 4 quarters · filed 2013-05-13 | |
| 2011-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$1.70M derived: sum of 2 quarters · filed 2013-03-29 | -$2.64M derived: sum of 3 quarters · filed 2013-03-29 | -$2.52M 10-K · filed 2013-03-29 | |
| 2011-09-30 | -$590.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.53M derived: sum of 2 quarters · filed 2012-11-09 | -$1.41M 10-Q · filed 2012-11-09 | -$1.37M derived: sum of 4 quarters · filed 2012-11-09 | |
| 2011-06-30 | -$944.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$818.00K 10-Q · filed 2012-08-14 | -$782.00K derived: sum of 3 quarters · filed 2012-08-14 | -$198.00K derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $126.00K 10-Q · filed 2012-05-11 | $162.00K derived: sum of 2 quarters · filed 2012-05-11 | $746.00K derived: sum of 3 quarters · filed 2012-05-11 | ||
| 2010-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $620.00K derived: sum of 2 quarters · filed 2012-03-30 | $264.00K 10-K · filed 2012-03-30 | ||
| 2010-09-30 | $584.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $228.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$356.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |